By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Iris International today announced that the US Food and Drug Administration has granted 510(k) clearance for its Nadia ProsVue prognostic cancer test for prostate cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.